{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:57:38Z","timestamp":1783605458966,"version":"3.55.0"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.prostaglandins.2019.106400","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T03:25:24Z","timestamp":1573701924000},"page":"106400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Cytochrome P450-derived eicosanoids and inflammation in liver diseases"],"prefix":"10.1016","volume":"147","author":[{"given":"Sherif M.","family":"Shoieb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud A.","family":"El-Ghiaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman O.S.","family":"El-Kadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2019.106400_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092732","article-title":"NLRP3 Inflammasome and IL-33: Novel Players in Sterile Liver Inflammation","volume":"19","author":"Neumann","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0010","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1056\/NEJMra1208937","article-title":"Acute liver failure","volume":"369","author":"Bernal","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0015","doi-asserted-by":"crossref","first-page":"9240","DOI":"10.3748\/wjg.v19.i48.9240","article-title":"Pathophysiology of cerebral oedema in acute liver failure","volume":"19","author":"Scott","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2593745","article-title":"Domino hepatocyte transplantation: a therapeutic alternative for the treatment of acute liver failure","volume":"2018","author":"Cardoso","year":"2018","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0025","first-page":"601","article-title":"Journey from hepatocyte transplantation to hepatic stem cells: a novel treatment strategy for liver diseases","volume":"123","author":"Aleem Khan","year":"2006","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D\u2019Amico","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0035","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","article-title":"Liver cirrhosis","volume":"383","author":"Tsochatzis","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0040","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0045","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1530\/JOE-13-0201","article-title":"Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance","volume":"218","author":"Asrih","year":"2013","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0050","doi-asserted-by":"crossref","first-page":"e8179","DOI":"10.1097\/MD.0000000000008179","article-title":"Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a meta-analysis","volume":"96","author":"Dai","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0055","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0060","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/hep.21248","article-title":"Statins and hepatic steatosis: perspectives from the Dallas heart study","volume":"44","author":"Browning","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0065","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.3748\/wjg.v16.i38.4773","article-title":"Hepatic steatosis, low-grade chronic inflammation and hormone\/growth factor\/adipokine imbalance","volume":"16","author":"Tarantino","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0070","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1053\/j.gastro.2016.01.025","article-title":"Inflammation in alcoholic and nonalcoholic fatty liver disease: friend or foe?","volume":"150","author":"Gao","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0075","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1146\/annurev-nutr-072610-145138","article-title":"Inflammation in alcoholic liver disease","volume":"32","author":"Wang","year":"2012","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1309\/AJCP2T2OHTAPBTMP","article-title":"Beyond \u201cCirrhosis,\u201d","volume":"137","author":"Hytiroglou","year":"2012","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0085","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3748\/wjg.v25.i5.521","article-title":"Iron and liver fibrosis: mechanistic and clinical aspects","volume":"25","author":"Mehta","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0090","series-title":"Highly Selective Targeting of Hepatic Stellate Cells for Liver Fibrosis Treatment Using a d-Enantiomeric Peptide Ligand of Fn14 Identified by Mirror-Image mRNA Display","author":"Huang","year":"2017"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0095","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.pharep.2019.01.008","article-title":"Antifibrotic effects of Fraxetin on carbon tetrachloride-induced liver fibrosis by targeting NF-\u03baB\/I\u03baB\u03b1, MAPKs and Bcl-2\/Bax pathways","volume":"71","author":"Wu","year":"2019","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/gast.2003.50013","article-title":"Histological outcome during long-term lamivudine therapy","volume":"124","author":"Dienstag","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.plefa.2018.03.004","article-title":"Omega-6 fatty acids and inflammation, Prostaglandins","volume":"132","author":"Innes","year":"2018","journal-title":"Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0110","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12576-012-0196-9","article-title":"Role of 15-lipoxygenase\/15-hydroxyeicosatetraenoic acid in hypoxia-induced pulmonary hypertension","volume":"62","author":"Zhu","year":"2012","journal-title":"J. Physiol. Sci."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0115","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbapap.2010.09.009","article-title":"Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids","volume":"1814","author":"Konkel","year":"2011","journal-title":"Biochim. Biophys. Acta Proteins Proteomics."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0120","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1124\/dmd.110.035287","article-title":"Activation of the acute inflammatory response alters cytochrome P450 expression and eicosanoid metabolism","volume":"39","author":"Theken","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0125","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.bbamem.2012.01.011","article-title":"Fatty acid composition of membrane bilayers: importance of diet polyunsaturated fat balance","volume":"1818","author":"Abbott","year":"2012","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-3084(03)00101-4","article-title":"Docosahexaenoic acid: membrane properties of a unique fatty acid","volume":"126","author":"Stillwell","year":"2003","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0135","series-title":"Hum. Brain Evol.","first-page":"13","article-title":"Long-chain polyunsaturated fatty acids in human brain evolution","author":"Crawford","year":"2010"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0140","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrn3820","article-title":"Polyunsaturated fatty acids and their metabolites in brain function and disease","volume":"15","author":"Bazinet","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0145","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev.nutr.24.121803.063211","article-title":"Structure, function, and dietary regulation of \u03946, \u03945, and \u03949 desaturases","volume":"24","author":"Nakamura","year":"2004","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/539426","article-title":"Health implications of high dietary Omega-6 polyunsaturated fatty acids","volume":"2012","author":"Patterson","year":"2012","journal-title":"J. Nutr. Metab."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0155","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s11745-005-1414-0","article-title":"Fatty acid composition of wild and farmed Atlantic salmon (Salmo salar) and rainbow trout (Oncorhynchus mykiss)","volume":"40","author":"Blanchet","year":"2005","journal-title":"Lipids"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0160","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.fitote.2018.04.003","article-title":"Reprint of: marine OMEGA-3 fatty acids in the prevention of cardiovascular disease","volume":"126","author":"Mori","year":"2018","journal-title":"Fitoterapia"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0165","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s40256-016-0170-7","article-title":"Omega-3 fatty acid formulations in cardiovascular disease: dietary supplements are not substitutes for prescription products","volume":"16","author":"Fialkow","year":"2016","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0170","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.3390\/md11103998","article-title":"Biosynthesis of polyunsaturated fatty acids in marine invertebrates: recent advances in molecular mechanisms","volume":"11","author":"Monroig","year":"2013","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0175","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.foodchem.2004.10.050","article-title":"Analysis of lipid classes and the fatty acid composition of the salted fish roe food products, Ikura, Tarako, Tobiko and Kazunoko","volume":"94","author":"Nobuya Shirai","year":"2006","journal-title":"Food Chem."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0180","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/0972060X.2014.989181","article-title":"Anti-inflammatory activity and chemical composition of essential oil extracted with supercritical CO2 from the brown seaweed undaria pinnatifida","volume":"19","author":"Kang","year":"2016","journal-title":"J. Essent. Oil Bearing Plants"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0185","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/fsn3.121","article-title":"Long-chain polyunsaturated fatty acid sources and evaluation of their nutritional and functional properties","volume":"2","author":"Abedi","year":"2014","journal-title":"Food Sci. Nutr."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0190","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1753-4887.2010.00287.x","article-title":"Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids","volume":"68","author":"Wall","year":"2010","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0195","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1388-1981(00)00077-9","article-title":"Metabolism of highly unsaturated n-3 and n-6 fatty acids","volume":"1486","author":"Sprecher","year":"2000","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0200","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.plefa.2006.05.013","article-title":"Metabolism of <em>\u03b1<\/em>-linolenic acid in humans, Prostaglandins","volume":"75","author":"Burdge","year":"2006","journal-title":"Leukot. Essent. Fat. Acids."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0205","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ahj.2005.03.051","article-title":"Understanding omega-3\u2032s","volume":"151","author":"DeFilippis","year":"2006","journal-title":"Am. Heart J."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0210","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1743-7075-6-8","article-title":"Quantitation of alpha-linolenic acid elongation to eicosapentaenoic and docosahexaenoic acid as affected by the ratio of n6\/n3 fatty acids","volume":"6","author":"Harnack","year":"2009","journal-title":"Nutr. Metab. (Lond)"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0215","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.plefa.2009.01.004","article-title":"International Society for the Study of Fatty Acids and Lipids, ISSFAL, $\u03b1$-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans, Prostaglandins","volume":"80","author":"Brenna","year":"2009","journal-title":"Leukot. Essent. Fat. Acids."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0220","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.biopha.2006.07.080","article-title":"Evolutionary aspects of diet, the omega-6\/omega-3 ratio and genetic variation: nutritional implications for chronic diseases","volume":"60","author":"Simopoulos","year":"2006","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0225","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jnutbio.2009.09.010","article-title":"N-3 polyunsaturated fatty acids regulate lipid metabolism through several inflammation mediators: mechanisms and implications for obesity prevention","volume":"21","author":"Tai","year":"2010","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0230","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jnutbio.2006.04.003","article-title":"Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid","volume":"18","author":"Weldon","year":"2007","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0235","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/07315724.2004.10719345","article-title":"Eicosapentaenoic acid prevents LPS-Induced TNF-\u03b1 expression by preventing NF-\u03baB activation","volume":"23","author":"Zhao","year":"2004","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0240","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/oby.2008.39","article-title":"Dietary fatty acids differentially regulate production of TNF-alpha and IL-10 by murine 3T3-L1 adipocytes","volume":"16","author":"Bradley","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0245","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/ajcn\/63.1.116","article-title":"The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil","volume":"63","author":"Mantzioris","year":"1996","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0250","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1079\/BJN2003892","article-title":"Inhibition of tumour necrosis factor-\u03b1 and interleukin 6 production by mononuclear cells following dietary fish-oil supplementation in healthy men and response to antioxidant co-supplementation","volume":"90","author":"Trebble","year":"2003","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0255","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.iy.12.040194.001041","article-title":"Function and activation of [1] P.A. baeuerle, T. Henkel, function and activation of NF-kappaB in the immune system, Annu. Rev. Immunol. 12 (1994) 141\u2013179. doi:. doi: 10.1146\/annurev.iy.12.040194.001041 .NF-kappaB in the immune system","volume":"12","author":"Baeuerle","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0260","doi-asserted-by":"crossref","first-page":"19927","DOI":"10.1074\/jbc.M803625200","article-title":"Electrophilic cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the peroxidation of the omega-3 polyunsaturated fatty acid docosahexaenoic acid","volume":"283","author":"Musiek","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0265","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0891-5849(03)00027-3","article-title":"Docosahexaenoic acid suppresses nitric oxide production and inducible nitric oxide synthase expression in interferon-\u03b3 plus lipopolysaccharide-stimulated murine macrophages by inhibiting the oxidative stress","volume":"34","author":"Komatsu","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0270","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cmet.2005.04.002","article-title":"\u201cNew\u201d hepatic fat activates PPAR\u03b1 to maintain glucose, lipid, and cholesterol homeostasis","volume":"1","author":"Chakravarthy","year":"2005","journal-title":"Cell Metab."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0275","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1093\/jn\/135.11.2503","article-title":"Fatty acid regulation of hepatic gene transcription","volume":"135","author":"Christian","year":"2005","journal-title":"J. Nutr."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0280","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1523-1755.2005.00151.x","article-title":"EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-\u03b3\u2013dependent mechanism","volume":"67","author":"Li","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0285","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1161\/01.ATV.0000137191.02577.86","article-title":"Oxidized Omega-3 fatty acids inhibit NF-\u03baB activation via a PPAR\u03b1-Dependent pathway","volume":"24","author":"Archana","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0290","doi-asserted-by":"crossref","first-page":"32048","DOI":"10.1074\/jbc.274.45.32048","article-title":"Peroxisome proliferator-activated receptor \u03b1 negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-\u03baB and AP-1","volume":"274","author":"Delerive","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0295","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/jn\/137.3.665","article-title":"Dietary fish oil increases the number of splenic macrophages secreting TNF-alpha and IL-10 but decreases the secretion of these cytokines by splenic T cells from mice","volume":"137","author":"Petursdottir","year":"2007","journal-title":"J. Nutr."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0300","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF01816941","article-title":"Influence of unsaturated fatty acids on the production of tumour necrosis factor and interleukin-6 by rat peritoneal macrophages","volume":"143","author":"Tappia","year":"1995","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0305","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.nut.2004.09.017","article-title":"Eicosapentaenoic acid modulates the immune response but has no effect on a mimic of antigen-specific responses","volume":"21","author":"Barber","year":"2005","journal-title":"Nutrition"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0310","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1523-1747.2002.01615.x","article-title":"Eicosapentaenoic acid, a n-3 polyunsaturated fatty acid differentially modulates TNF-\u03b1, IL-1\u03b1, IL-6 and PGE2 expression in UVB-Irradiated human keratinocytes","volume":"118","author":"Pupe","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0315","doi-asserted-by":"crossref","first-page":"768","DOI":"10.5713\/ajas.2007.768","article-title":"The effect of dietary docosahexaenoic acid enrichment on the expression of porcine hepatic genes","volume":"20","author":"Chang","year":"2007","journal-title":"Asian Aust. J. Anim. Sci."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0320","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jnutbio.2009.01.004","article-title":"Docosahexaenoic acid regulates serum amyloid A protein to promote lipolysis through down regulation of perilipin","volume":"21","author":"Wang","year":"2010","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0325","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/jn\/138.4.674","article-title":"Serum amyloid a protein regulates the expression of porcine genes related to lipid metabolism","volume":"138","author":"Liu","year":"2008","journal-title":"J. Nutr."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0330","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0165-2478(90)90073-Y","article-title":"Interleukin-1 and tumor necrosis factor synthesis by mouse peritoneal macrophages is enhanced by dietary n-3 polyunsaturated fatty acids","volume":"23","author":"Lokesh","year":"1990","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0335","doi-asserted-by":"crossref","first-page":"32239","DOI":"10.1074\/jbc.M109.024661","article-title":"Docosahexaenoic acid enhances hepatic serum amyloid A expression via protein kinase A-dependent mechanism","volume":"284","author":"Tai","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0340","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.ejphar.2011.05.085","article-title":"Fatty acids and inflammation: the cutting edge between food and pharma","volume":"668","author":"Calder","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0345","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.lfs.2018.04.049","article-title":"Omega-3 and omega-6 polyunsaturated fatty acids: dietary sources, metabolism, and significance \u2014 a review","volume":"203","author":"Saini","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0350","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jare.2018.03.005","article-title":"Synopsis of arachidonic acid metabolism: a review","volume":"11","author":"Hanna","year":"2018","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0355","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1194\/jlr.M600396-JLR200","article-title":"Upregulated liver conversion of \u03b1-linolenic acid to docosahexaenoic acid in rats on a 15 week n-3 PUFA-deficient diet","volume":"48","author":"Igarashi","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0360","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1194\/jlr.M700315-JLR200","article-title":"Dietary n-3 PUFA deprivation for 15 weeks upregulates elongase and desaturase expression in rat liver but not brain","volume":"48","author":"Igarashi","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0365","doi-asserted-by":"crossref","first-page":"24431","DOI":"10.1074\/jbc.X116.723791","article-title":"Liberating chiral lipid mediators, inflammatory enzymes, and LIPID MAPS from biological grease","volume":"291","author":"Dennis","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0370","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1021\/cr2002992","article-title":"Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis","volume":"111","author":"Smith","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0375","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.bbalip.2014.10.008","article-title":"Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid","volume":"1851","author":"Powell","year":"2015","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0380","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.3390\/ijms19113285","article-title":"Arachidonic acid metabolites in cardiovascular and metabolic diseases","volume":"19","author":"Sonnweber","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0385","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.alit.2017.12.002","article-title":"Efficacy of tiotropium in adults with moderate asthma, by leukotriene receptor antagonist use at baseline","volume":"67","author":"Hashimoto","year":"2018","journal-title":"Allergol. Int."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0390","series-title":"Lipoxygenases Inflamm","first-page":"185","article-title":"5-Oxo-ETE and inflammation","author":"Powell","year":"2016"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0395","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1073\/pnas.1422590112","article-title":"Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides","volume":"112","author":"L\u00f3pez-Vicario","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0400","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nrgastro.2013.211","article-title":"Liver autophagy: much more than just taking out the trash","volume":"11","author":"Schneider","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0405","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2015.03.083","article-title":"Lipoxins and aspirin-triggered lipoxins in resolution of inflammation","volume":"760","author":"Romano","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0410","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2015.03.083","article-title":"Lipoxins and aspirin-triggered lipoxins in resolution of inflammation","volume":"760","author":"Romano","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111006","article-title":"Comparative analysis and modeling of the severity of steatohepatitis in DDC-Treated mouse strains","volume":"9","author":"Pandey","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0420","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.plefa.2016.05.006","article-title":"Low immune cell ARA and high plasma 12-HETE and 17-HDHA in iron-deficient South African school children with allergy, Prostaglandins","volume":"110","author":"Malan","year":"2016","journal-title":"Leukot. Essent. Fat. Acids."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0425","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jaad.2018.05.1251","article-title":"12-Hydroxyeicosatetraenoic acid levels are increased in actinic keratoses and squamous cell carcinoma","volume":"79","author":"Laquer","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0430","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.bbalip.2014.09.007","article-title":"Pathophysiology of the hepoxilins","volume":"1851","author":"Pace-Asciak","year":"2015","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0435","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/cyto.2002.2007","article-title":"In vitro effects of eicosanoids derived from different 20-carbon Fatty acids on production of monocyte-derived cytokines in human whole blood cultures","volume":"20","author":"Miles","year":"2002","journal-title":"Cytokine"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0440","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/bbrc.2001.6155","article-title":"Endogenous anti-inflammatory mediators from Arachidonate in human neutrophils","volume":"290","author":"Vachier","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0445","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.4049\/jimmunol.168.10.5260","article-title":"Lipoxin a4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis","volume":"168","author":"Gewirtz","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0450","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/89759","article-title":"Lipid mediator class switching during acute inflammation: signals in resolution","volume":"2","author":"Levy","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0455","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.bbalip.2010.08.002","article-title":"Specialized pro-resolving lipid mediators in the inflammatory response: an update","volume":"1801","author":"Bannenberg","year":"2010","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0460","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.coph.2013.05.012","article-title":"Resolution phase lipid mediators of inflammation: agonists of resolution","volume":"13","author":"Serhan","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0465","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3390\/md17050274","article-title":"Intravenous lipid emulsions to deliver bioactive Omega-3 fatty acids for improved patient outcomes","volume":"17","author":"Calder","year":"2019","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0470","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1134\/S0006297908090022","article-title":"New findings in studies of cytochromes P450","volume":"73","author":"Myasoedova","year":"2008","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0475","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/138920008783571774","article-title":"Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues","volume":"9","author":"Pavek","year":"2008","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0480","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pharmthera.2017.05.005","article-title":"Cytochrome P450-derived eicosanoids and heart function","volume":"179","author":"Jamieson","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0485","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1124\/dmd.118.082073","article-title":"S- enantiomer of 19-Hydroxyeicosatetraenoic acid preferentially protects against angiotensin II-Induced cardiac hypertrophy","volume":"46","author":"Shoieb","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0490","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11010-017-2943-y","article-title":"The role of cytochrome P450 1B1 and its associated mid-chain hydroxyeicosatetraenoic acid metabolites in the development of cardiac hypertrophy induced by isoproterenol","volume":"429","author":"Maayah","year":"2017","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0495","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.yjmcc.2009.10.022","article-title":"Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation","volume":"48","author":"Deng","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0500","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids","volume":"285","author":"Node","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0505","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1124\/jpet.107.130336","article-title":"20-hydroxyeicosatetraenoic acid stimulates nuclear factor- B activation and the production of inflammatory cytokines in human endothelial cells","volume":"324","author":"Ishizuka","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0510","series-title":"Extracellular Matrix, Asthma COPD","first-page":"265","author":"Barnes","year":"2009"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0515","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0520","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0525","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","article-title":"Mechanisms of hepatic fibrogenesis","volume":"25","author":"Lee","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0530","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2131\/jts.32.453","article-title":"Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis","volume":"32","author":"Nagata","year":"2007","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0535","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/B978-0-12-398456-2.00051-7","article-title":"Protection and reversal of hepatic fibrosis by polyphenols","author":"Janel","year":"2014","journal-title":"Polyphenols Hum. Heal. Dis."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0540","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s40139-015-0093-z","article-title":"TNF\u03b1 in liver fibrosis","volume":"3","author":"Yang","year":"2015","journal-title":"Curr. Pathobiol. Rep."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0545","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/1389200043335531","article-title":"Cytochrome P450 and liver diseases","volume":"5","author":"Villeneuve","year":"2004","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0550","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2018-316091","article-title":"HBV infection-induced liver cirrhosis development in dual-humanised mice with human bone mesenchymal stem cell transplantation","author":"Yuan","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0555","first-page":"661","article-title":"Patterns of expression of cytochrome P450 genes in progression of hepatitis C virus-associated hepatocellular carcinoma","volume":"27","author":"Tsunedomi","year":"2005","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0560","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0006-2952(94)00515-N","article-title":"Pre-translational regulation of cytochrome P450 genes is responsible for disease-specific changes of individual P450 enzymes among patients with cirrhosis","volume":"49","author":"George","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0565","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3748\/wjg.v9.i2.359","article-title":"Different alterations of cytochrome P450 3A4 isoform and its gene expression in livers of patients with chronic liver diseases","volume":"9","author":"Yang","year":"2003","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0570","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.clpt.2006.05.006","article-title":"Liver disease selectively modulates cytochrome P450\u2013mediated metabolism","volume":"80","author":"Frye","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0575","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0898-6568(01)00243-1","article-title":"Lipopolysaccharide-induced release of arachidonic acid and prostaglandins in liver macrophages: regulation by Group IV cytosolic phospholipase A2, but not by Group V and Group IIA secretory phospholipase A2","volume":"14","author":"Dieter","year":"2002","journal-title":"Cell. Signal."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0580","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1124\/dmd.110.035287","article-title":"Activation of the acute inflammatory response alters cytochrome P450 expression and eicosanoid metabolism","volume":"39","author":"Theken","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0585","article-title":"Lipid mediators in inflammation","volume":"4","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0590","doi-asserted-by":"crossref","first-page":"9772","DOI":"10.1073\/pnas.0503279102","article-title":"Soluble epoxide hydrolase is a therapeutic target for acute inflammation","volume":"102","author":"Schmelzer","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0595","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.metabol.2016.10.002","article-title":"Amelioration of non-alcoholic fatty liver disease with NPC1L1-targeted IgY or n-3 polyunsaturated fatty acids in mice","volume":"66","author":"Bae","year":"2017","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0600","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","article-title":"Non-alcoholic fatty liver disease and dyslipidemia: an update","volume":"65","author":"Katsiki","year":"2016","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0605","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0610","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cmet.2012.04.004","article-title":"Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease","volume":"15","author":"Min","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0615","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0620","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/gutjnl-2011-300269","article-title":"Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice","volume":"61","author":"Ye","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0625","first-page":"1207","article-title":"Inhibition of 5-lipoxygenase inhibitor zileuton in high-fat diet-induced nonalcoholic fatty liver disease progression model","volume":"20","author":"Ma","year":"2017","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0630","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.jdiacomp.2017.07.014","article-title":"Molecular mechanisms of nonalcoholic fatty liver disease: potential role for 12-lipoxygenase","volume":"31","author":"Samala","year":"2017","journal-title":"J. Diabetes Complications"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0635","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110162","article-title":"The cytochrome P450 epoxygenase pathway regulates the hepatic inflammatory response in fatty liver disease","volume":"9","author":"Schuck","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0640","first-page":"E97","article-title":"CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice","volume":"308","author":"Chen","year":"2015","journal-title":"Am. J. Physiol. Metab."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0645","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/liv.12541","article-title":"Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC\/MS and UPLC\/MS-MS","volume":"34","author":"Fitian","year":"2014","journal-title":"Liver Int."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0650","first-page":"193","article-title":"Inhibition of 12-lipoxygenase reduces proliferation and induces apoptosis of hepatocellular carcinoma cells in vitro and in vivo., Hepatobiliary Pancreat","volume":"11","author":"Xu","year":"2012","journal-title":"Dis. Int."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0655","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1038\/onc.2017.73","article-title":"Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice","volume":"36","author":"Chen","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0660","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1158\/1078-0432.CCR-17-2725","article-title":"COX-2\/PGE2 Axis Regulates HIF2\u03b1 activity to promote hepatocellular carcinoma hypoxic response and reduce the sensitivity of sorafenib treatment","volume":"24","author":"Dong","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0665","doi-asserted-by":"crossref","first-page":"63890","DOI":"10.18632\/oncotarget.19173","article-title":"Metabolomics and eicosanoid analysis identified serum biomarkers for distinguishing hepatocellular carcinoma from hepatitis B virus-related cirrhosis","volume":"8","author":"Gong","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0670","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/carcin\/bgr049","article-title":"Suppressed liver tumorigenesis in fat-1 mice with elevated omega-3 fatty acids is associated with increased omega-3 derived lipid mediators and reduced TNF-\u03b1","volume":"32","author":"Weylandt","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0675","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1096\/fj.06-6250fje","article-title":"Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA","volume":"20","author":"Gonz\u00e1lez-P\u00e9riz","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.prostaglandins.2019.106400_bib0680","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3748\/wjg.v24.i4.461","article-title":"Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity\/nonalcoholic fatty liver disease model in mice","volume":"24","author":"Rodriguez-Echevarria","year":"2018","journal-title":"World J. Gastroenterol."}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882319301510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882319301510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:01:30Z","timestamp":1761098490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882319301510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":136,"alternative-id":["S1098882319301510"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2019.106400","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytochrome P450-derived eicosanoids and inflammation in liver diseases","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2019.106400","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106400"}}